Article 30(3) opinions

This pages lists the opinions drawn up by the ">Committee for Medicinal Products for Veterinary Use (CVMP) on any scientific matter related to the evaluation of medicines for use in animals. The Committee must draw up such an opinion at the request of the Executive Director of the European Medicines Agency or of the European Commission. It may also draw up an opinion following a request from a Member State.

Where the scientific issue concerns both human and veterinary medicines, the Committee may adopt a common opinion with the Committee for Medicinal Products for Human Use (CHMP).

Requests for this type of scientific opinion fall under Article 30(3) of Regulation (EC) No 726/2004.

Potential risk for the consumer resulting from the use of lidocaine in food producing species

Retrovirus RD114 in live attenuated vaccines for use in animals

Risk for the consumer resulting from the use of diethanolamine as an excipient in veterinary medicinal products for food-producing species

Risks to vultures and other necrophagous bird populations in the Union in connection with the use of veterinary medicinal products containing the substance diclofenac


How useful was this page?

Add your rating